Genomic Landscape and Clinical Features of Carcinomas with ERBB2 S310 Extracellular Domain Mutations

被引：0
|
作者：
Desmeules, Patrice [1 ]
Zehir, Ahmet [1 ]
Hyman, David M. [1 ]
Arcila, Maria E. [1 ]
Ladanyi, Marc [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1831
引用
收藏
页码：456A / 456A
页数：1
相关论文
共 50 条
  • [21] Micropapillary histology (MPUC) and extra-cellular domain ERBB2 (ERBB2 ECD+) mutations in urothelial bladder cancer (UBC)
    Sood, A.
    Jacob, J. M.
    Bratslavsky, G.
    Grivas, P.
    Spiess, P.
    Li, R.
    Necchi, A.
    Posada, J.
    Yakirevich, E.
    Cheng, L.
    Pavlick, D. C.
    Huang, R.
    Lin, D. I.
    Danziger, N. A.
    Sokol, E. S.
    Sivakumar, S.
    Ross, J. S.
    Kamat, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1219 - S1220
  • [22] Clinicopathological Features of Insertion Mutations in Kinase Domain of EGFR and ERBB2 in Non-Small-Cell Lung Cancer
    Zhao, Ruiying
    Xiang, Chan
    Zhu, Lei
    Shao, Jinchen
    Zhao, Jikai
    Guo, Lianying
    Ma, Shengji
    Yu, Anbo
    Han, Yuchen
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1833 - 1834
  • [23] Clinicopathological Features of Insertion Mutations in Kinase Domain of EGFR and ERBB2 in Non-Small-Cell Lung Cancer
    Zhao, Ruiying
    Xiang, Chan
    Zhu, Lei
    Shao, Jinchen
    Zhao, Jikai
    Guo, Lianying
    Ma, Shengji
    Yu, Anbo
    Han, Yuchen
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1833 - 1834
  • [24] Characterizing the Genomic Landscape of Micropapillary Variant of Urothelial Carcinoma of the Bladder Harboring Activating Extra-Cellular Mutations of the ERBB2 Gene
    Posada, Jessica
    Yakirevich, Evgeny
    Ross, Jeffrey
    Cheng, Liang
    LABORATORY INVESTIGATION, 2023, 103 (03) : S789 - S789
  • [25] The genomic landscape of urothelial carcinoma with high and low ERBB2/HER2 expression.
    Hadadi, Agreen
    Krause, Harris
    Elliott, Andrew
    Farrell, Alex Patrick
    Brown, Jacqueline T.
    Nazha, Bassel
    Harik, Lara
    Carthon, Bradley Curtis
    Nabhan, Chadi
    Barata, Pedro C.
    Saleh, Mohamed
    Yang, Yuanquan
    Korn, W. Michael
    Mckay, Rana R.
    Bilen, Mehmet Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [26] Targeting HER2 in Colorectal Cancer: The Landscape of Amplification and Short Variant Mutations in ERBB2 and ERBB3
    Ross, Jeffrey S.
    Fakih, Marwan
    Ali, Siraj M.
    Elvin, Julia A.
    Schrock, Alexa B.
    Suh, James
    Vergilio, Jo-Anne
    Ramkissoon, Shakti
    Severson, Eric
    Daniel, Sugganth
    Fabrizio, David
    Frampton, Garrett
    Sun, James
    Miller, Vincent A.
    Stephens, Philip J.
    Gay, Laurie M.
    CANCER, 2018, 124 (07) : 1358 - 1373
  • [27] Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations
    Pahuja, Kanika Bajaj
    Nguyen, Thong T.
    Jaiswal, Bijay S.
    Prabhash, Kumar
    Thaker, Tarjani M.
    Senger, Kate
    Chaudhuri, Subhra
    Kljavin, Noelyn M.
    Antony, Aju
    Phalke, Sameer
    Kumar, Prasanna
    Mravic, Marco
    Stawiski, Eric W.
    Vargas, Derek
    Durinck, Steffen
    Gupta, Ravi
    Khanna-Gupta, Arati
    Trabucco, Sally E.
    Sokol, Ethan S.
    Hartmaier, Ryan J.
    Singh, Ashish
    Chougule, Anuradha
    Trivedi, Vaishakhi
    Dutt, Amit
    Patil, Vijay
    Joshi, Amit
    Noronha, Vanita
    Ziai, James
    Banavali, Sripad D.
    Ramprasad, Vedam
    DeGrado, William F.
    Bueno, Raphael
    Jura, Natalia
    Seshagiri, Somasekar
    CANCER CELL, 2018, 34 (05) : 792 - +
  • [28] Irreversible inhibitors overcome lapatinib resistance due to ERBB2 kinase domain mutations
    Kancha, R. K.
    von Bubnoff, N.
    Bartosch, N.
    Peschel, C.
    Engh, R. A.
    Duyster, J.
    ONKOLOGIE, 2011, 34 : 118 - 118
  • [29] The overexpression of a single oncogene (ERBB2/HER2) alters the proteomic landscape of extracellular vesicles
    Amorim, Maria
    Fernandes, Gustavo
    Oliveira, Paulo
    Martins-de-Souza, Daniel
    Dias-Neto, Emmanuel
    Nunes, Diana
    PROTEOMICS, 2014, 14 (12) : 1472 - 1479
  • [30] Pre-clinical In Vitro and In Vivo Characterization of a Novel EGFR Sparing ErbB2 Inhibitor with Activity Against Oncogenic ErbB2 Mutations
    Chicarelli, M. J.
    Bouhana, K.
    Cable, L.
    Crow, M.
    Fell, B.
    Fischer, J.
    Fulton, J.
    Guarnieri, A.
    Jalluri, R.
    Robinson, J.
    Sullivan, F.
    Winski, S.
    Zhou, Y.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S81 - S81
12345